The inhibitory properties of a series of synthetic epimers and analogues of swainsonine towards the multiple forms of human a-mannosidases were studied in vitro and in cells in culture. Of the five epimers tested, only the 8a-epimer and 8,8a-diepimer of swainsonine were specific and competitive inhibitors (K1 values of 7.5 x 10-5 and 2 x 10-6 M respectively) of lysosomal a-mannosidases in vitro and induced storage of mannoserich oligosaccharides in human fibroblasts in culture. The structures of these storage products indicated that processing a-mannosidases had also been inhibited. This was consistent with the observed inhibition in vitro of these enzymes by these compounds. In contrast, the 8-epimer, 1,8-diepimer and 2,8a-diepimer of swainsonine had no appreciable effect on any ac-mannosidases. The corresponding open-chain analogues of swainsonine, namely 1,4-dideoxy-1,4-imino-D-mannitol, of the 8a-epimer, namely 1,4-dideoxy-1,4-imino-Dtalitol, and of the 8,8a-diepimer, namely 1,4-dideoxy-1,4-imino-L-allitol, were weaker competitive inhibitors of lysosomal a-mannosidase, with Ki values of 1.3 x 10-5, 1.2 x 10' and 1.2 x 10-4 M respectively. These analogues also proved less effective at inducing oligosaccharide accumulation and in disturbing glycoprotein processing. These compounds offer the opportunity to determine which alterations in the chirality of the swainsonine molecule affect its inhibitory specificity. A comparison of their biological activities has identified reagents that will be useful for studying steps in the biosynthesis and catabolism of glycoproteins and that may be of potential value in chemotherapy.
INTRODUCTION
Many naturally occurring or synthetic polyhydroxylated indolizidine, piperidine and pyrrolidine alkaloids are specific and potent inhibitors of mammalian glycosidases (Fellows, 1986; Elbein, 1987) . They are used extensively to inhibit processing glycosidases to assess the effect of changes in glycosylation on the properties and functions of glycoproteins (Schwarz & Datema, 1984; Fuhrmann et al., 1985) . Changes in glycosylation are associated with many disease processes, and the therapeutic value of these compounds as anti-metastatic (Humphries et al., 1986) , anti-tumour-proliferation (Dennis, 1986) and antiviral (Tyms et al., 1987; Gruters et al., 1987 ) agents is currently being tested. Many of these compounds are lysosomotropic on account of their weakly basic nature, and have been used to induce reversible deficiencies of lysosomal glycosidases in vivo (Huxtable & Dorling, 1982; Saul et al., 1985) and in cells in culture (Cenci di Bello et al., 1983) . This can produce a phenocopy of the lysosomal storage disease that results from a genetic deficiency of the same enzyme. Such model systems can be used to study the dynamics of storage-product accumulation and their dispersal on restoration of enzymic activity on withdrawal of the inhibitor (Cenci di Bello et al., 1983) , and to identify reversible and irreversible steps in pathogenetic mechanisms (Huxtable & Dorling, 1982) .
Mammalian a-mannosidase exists in genetically and structurally distinct multiple forms, which differ in their pH optima and subcellular locations (Winchester, 1984) . Swainsonine (1 S,2R,8R,8aR)-1 ,2,8-trihydroxyoctohydroindolizine) is a known potent and specific inhibitor of lysosomal and some of the processing forms of amannosidase (Dorling et al., 1980; Tulsiani et al., 1982; Cenci di Bello et al., 1983) . To gain some understanding of the specificity of this inhibition and to identify novel reagents for studying the metabolism of glycoproteins, the inhibitory effects of a series of isomers and analogues of swainsonine towards the different forms of human amannosidase have been investigated.
MATERIALS AND METHODS

Tissue
Post-mortem human liver, which had been stored at -20°C until required, was homogenized (5000 w/v) in 10 mM-sodium phosphate buffer, pH 6.0, in a PotterElvehjem homogenizer and then centrifuged at 37000 g for 30 min in an MSE 18 centrifuge. The resultant supernatant was used as the source of enzymic activities.
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Abbreviations used: DIM, 1,4-dideoxy-I,4-imino-D-mannitol; DIT, 1, Cell culture Normal human fibroblasts and fibroblasts from a patient with mannosidosis were grown and extracts were prepared as described previously (Burditt et al., 1978) . The uptake of swainsonine and analogues into fibroblasts in culture and the measurement of internalized inhibitor was carried out as before (Chotai et al., 1983) . Swainsonine analogues Swainsonine was kindly provided by Professor P. Dorling, Murdoch University, Perth, Western Australia, Australia. The 8-epimer (Iimura et al., 1986) , 8a-epimer (Tadano et al., 1987) , 1,8-diepimer, 2,8a-diepimer and 8,8a-diepimer of swainsonine (Tadano et al., 1988) , 1,4-dideoxy-1,4-imino-D-mannitol (DIM) (Bashyal et al., 1987) and 1,4-dideoxy-1,4-imino-D-talitol (DIT) were all synthesized and characterized in our laboratories as described previously. 1,4-Dideoxy-1,4-imino-L-allitol (DIA) was prepared from L-gulonolactone by the same method as that used to synthesize 1,4-dideoxy-1,4-imino-D-allitol from D-gulonolactone . Their structures are shown in Fig. 1 .
Enzyme assays
Glycosidase activities in extracts of normal human liver and fibroblasts were assayed by using the appropriate fluorigenic 4-methylumbelliferyl glycoside substrate (Koch-Light, Haverhill, Suffolk, U.K.) at a concentration of 0.5 mm at the pH optimum of each enzyme (Burditt et al., 1980) . Human liver acidic (lysosomal) and neutral (cytosolic) a-mannosidases were similarly assayed at their pH optima of 4.0 and 6.5, after separation by affinity chromatography on concanavalin A-Sepharose (Pharmacia, Milton Keynes, Bucks., U.K.) (Phillips et al., 1976) . The residual intermediate (Golgi) a-mannosidase II activity in extracts of mannosidosis fibroblasts was assayed at pH 5.75 with the synthetic substrate. Preliminary screening for inhibitory properties was achieved by assaying the multiple forms of o-Dmannosidase and ten other glycosidases in the presence and in the absence of a 1 mm solution of each compound. The nature of the inhibition of the a-D-mannosidase and the value of the K1 were determined by using the Dixon graphical procedure. Isolation and analysis of neutral oligosaccharides from fibroblasts Neutral oligosaccharides were isolated from normal human fibroblasts grown in the presence of inhibitors and from urine and fibroblasts from a patient with genetic mannosidosis and analysed by t.l.c. as previously described (Cenci di Bello et al., 1983) . In some experiments the relative proportions of the induced storage products were estimated by densitometry with the use of a Joyce-Loebl Chromoscan 3 scanning densitometer. the hydroxy groups and the bridge hydrogen atom (8a) of swainsonine had a marked effect on the efficacy of inhibition (Table 1 and Fig. 1 ). The 8-epimer was a very poor inhibitor of a-mannosidase. In contrast, alteration of the configuration at the bridge 8a position did not destroy the ability to inhibit and even appeared to contribute to an inhibitory structure in the 8,8a-diepimer. However, the 1,8-anid 2,8a-diepimers of swainsonine were inactive towards a-mannosidase. The 2-epimer and the 2,8-diepimer have previously been shown not to inhibit a-mannosidase . From these observations, it is concluded that, for the effective inhibition of acidic a-mannosidase, the configuration of the 1-and 2-hydroxy groups in swainsonine epimers must be IS and 2R. However, this is not the total requirement, because the 8-epimer and 8-deoxyswainsonine (Colegate et al., 1985) , which also possess this configuration, do not inhibit a-mannosidase. DIM, the azafuranose analogue of mannose and an open-chain analogue of swainsonine, is a powerful inhibitor of acidic a.-mannosidase (Fleet et al., 1984) . Therefore the corresponding azafuranose analogues of the two active swainsonine epimers, the 8a-epimer ('Dtalo') and the 8,8a-diepimer ('L-allo'), were similarly tested. Both DIT and DIA were specific competitive inhibitors of acidic a-mannosidase. This confirmed that it is the configuration of the substituents on atoms 1, 2, 8a and 8, corresponding to atoms 2, 3, 4 and 5 in mannose, that determines the inhibitory properties of swainsonine.
RESULTS AND DISCUSSION
swainsonine 1 ,4-Dideoxy-1,4- imino-D-mannitol (DIM) 1 ,4-Dideoxy-1,4- imino-D-talitol (DIT) 1 ,4-Dideoxy-1,4- imino-L-allitol (DIA)
Inhibition of other acidic glycosidases
Swainsonine is a specific inhibitor of a-D-mannosidase Effect of pH on the inhibition of acidic and neutral oc-mannosidases The inhibition of glycosidases by indolizidine alkaloids (Saul et al., 1984) and pyrrolidine alkaloids (Palamarczyk et al., 1985) is pH-dependent. This could be due to the effect of pH on the state of ionization of the inhibitor or of the enzyme. In the case of crude preparations of human a-mannosidases, there could also be a differential effect on the multiple forms of oc-mannosidase, which have distinct pH optima, subcellular locations and functions (Winchester, 1984) . To clarify this effect, the lysosomal (acidic) and cytosolic (neutral) oc-mannosidases that are present in aqueous extract of human liver were separated by affinity chromatography on concanavalin A-Sepharose (Phillips et al., 1976) . The inhibition of lysosomal a-mannosidase by swainsonine and the 8a-epimer and 8,8a-diepimer of swainsonine and their open-chain analogues, DIM, DIT and DIA, increased with pH, reaching a limiting value at pH 6.0 (Fig. 2a) . This observation suggests that the inhibition depends on the ionization of a group with a pK between 4.1 and 4.6. The values of pK for the ring nitrogen atom in swainsonine and that in DIM are 7.4 (Dorling et al., 1980 ) and 7.5 respectively. The values of pK for the nitrogen atom in the other swainsonine and azafuranose isomers that have also been shown to be inhibitory are likely to be similar. Thus the inhibitors are positively charged throughout the pH range over which the inhibition varies. Therefore it is concluded that the pHdependence of inhibition is determined by the state of ionization of a group(s) on the enzyme rather than on the inhibitors. A carboxy group has been implicated in the catalytic mechanism of ac-mannosidase (De Prijcker (Fig. 2a) .
Only swainsonine and to a much lesser extent the 8,8a-diepimer and the azafuranoses inhibited neutral amannosidase (Fig. 2b) . Inhibition increased with pH up to pH 6.5 and then remained constant or decreased slightly, suggesting that both the ionized and un-ionized forms of the inhibitors can inhibit this enzyme. This indicates that lysosomal and cytosolic a-mannosidases have different mechanisms of action, as would have been expected from our previous kinetic studies (Hirani & Winchester, 1979) . Inhibition of Golgi oc-mannosidase II in vitro Fibroblasts from patients with the lysosomal storage disease mannosidosis are deficient in acidic amannosidase. The residual activity in these cells towards the synthetic substrate has an optimal pH of 5.75 and is due to Golgi a-mannosidase II. Table I summarizes the effect in vitro of the various inhibitors on this Golgi a-mannosidase activity as well as on the lysosomal and cytosolic forms of the enzyme. The Golgi amannosidase II is particularly sensitive to inhibition in vitro. The formation of an ion-pair between the protonated inhibitor and a carboxylate group on the enzyme may also explain the susceptibility of this enzyme to inhibition.
Inhibition of a-mannosidases in vivo
Swainsonine is taken up into fibroblasts in culture in a concentration-, time-and temperature-dependent manner (Chotai et al., 1983) . The very high intracellular concentration of swainsonine that results has been attributed to its weakly basic nature, leading to its accumulation within lysosomes and other subcellular compartments with a low pH. The swainsonine-induced accumulation of mannose-rich oligosaccharides in lysosomes of such cells and their dispersal on removal of the inhibitor provide experimental evidence for the lysosomotropic nature of swainsonine (Cenci di Bello et al., 1983) . The structures of the induced storage products show that swainsonine has also altered the processing of the glycoproteins by inhibiting the Golgi a-mannosidase II and the endoplasmic-reticulum (cytosolic) amannosidase form or the Golgi a-mannosidase I (Cenci di Bello et al., 1983; Winchester, 1984) .
These observations are consistent with the inhibition of a-mannosidase in vitro, by swainsonine, reported in the present paper. Thus, if a swainsonine analogue inhibits lysosomal a-mannosidase in vitro and is lysosomotropic, it should lead to accumulation of oligomannosides. By comparing the pattern of storage products induced in fibroblasts by swainsonine isomers and analogues with the known patterns produced in swainsonine and genetically induced mannosidosis, it is possible to deduce the specificity of inhibition of these compounds in vivo. Preliminary experiments showed that the 8a-epimer and 8,8a-diepimer of swainsonine and DIM, DIT and DIA were taken up into normal fibroblasts from the culture medium in a concentration-and time-dependent manner similar to that observed for swainsonine. Therefore cells were grown in the presence of these inhibitors for 1 week and analysed for the induction of storage products (Fig. 3) . Clearly the 8,8a-diepimer and 8a-epimer of swainsonine, which inhibited the lysosomal amannosidase in vitro, caused accumulation of oligosaccharides, indicating that this enzyme was also affected in vivo. In contrast, the 1,8-diepimer of swainsonine, (Monis et al., 1987) . By implication, the 8a-epimer of swainsonine has no effect on this activity whereas swainsonine and its 8, (Fig. 4) . DIM, the analogue of swainsonine, was not a very effective inducer of storage products, and a higher concentration (5 mM) and a longer contact time had to be used. The main oligosaccharides produced were Man2GlcNAc and Man3GlcNAc, but smaller amounts of Man5GlcNAc, Man6GlcNAc and particularly Man7GlcNAc were detected, suggesting that Golgi a-mannosidase I or the endoplasmic-reticulum a-mannosidase had been inhibited. A similar conclusion about the effect of this compound on the processing of glycoproteins has been reached by other groups (Palamarczyk et al., 1985; Daniel et al., 1987 ----s{----- these compounds, unlike swainsonine and its 8,8a-diepimer, do not inhibit the minor lysosomal amannosidase, which is unaffected in genetic mannosidosis.
CONCLUSIONS
Several interesting and novel inhibitors of lysosomal and processing a-mannosidases have been described in this paper. They will be useful in elucidating more steps in the post-translational modification of glycoproteins and their catabolism. In general, it is possible to predict their specificity of inhibition in vivo from their action in vitro. However, the kinetic experiments do not give any clues as to the lysosomotropic nature of the compound or its ability to penetrate the plasma membrane or other intracellular membranes. Although the pK values of the ring nitrogen atoms of the indolizidine and pyrrolidine alkaloids are similar, the swainsonine epimers were more effective in inducing accumulation of partially catabolized glycans. The structural basis of this observation needs to be investigated in view of the potential chemotherapeutic value of these compounds.
